Cancer Metastasis: Biologic Basis and Therapeutics

Name: Cancer Metastasis: Biologic Basis and Therapeutics
Brand: Cambridge University Press
SKU: 9780521887212
Price: 148.19 EUR
Availability: InStock

★★★★★

English

Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed. See more

€148.19

€155.99

Save 5%

Quantity

Age Group_Uncategorizedautomatic-updateB01=Bethan PsailaB01=Danny R. WelchB01=David C. LydenB01=David LydenCategory1=Non-FictionCategory=MJCLCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch

Delivery/Collection within 10-20 working days

Product Details

Weight: 2050g
Dimensions: 223 x 287mm
Publication Date: 25 Apr 2011
Publisher: Cambridge University Press
Publication City/Country: United Kingdom
Language: English
ISBN13: 9780521887212

About

David Lyden is the Stavros S. Niarchos Associate Professor in Pediatrics and Cell and Developmental Biology at the Children's Cancer and Blood Foundation Laboratories at Weill Cornell Medical College. He is a Neuro-oncologist at Memorial Sloan-Kettering Cancer Center. Also Dr Lyden is an Investigator of the Champalimaud Foundation the first research prevention and treatment center for metastatic disease. In 2007 he received the Presidential Medical Distinction Award from President Cavaco Silva of Portugal. Danny R. Welch is Leonard H. Robinson Professor of Pathology at the University of Alabama Birmingham. He actively holds numerous titles in various organizations such as Co-Chair of the Program and Education Committees of American Association of Cancer Research editor-in-chief of Clinical and Experimental Metastasis and Chair of the Cancer Genetics Study Section at the National Institute of Health. Dr Welch has published six books and holds five patents. Bethan Psaila is a Research Fellow at Imperial College of Medicine in London and Weill Cornell Medical College of New York. Dr Psaila is the recipient of a Fulbright Scholarship in Cancer Research and a Kay Kendall Leukaemia Fund Travelling Fellowship.